[Chemotherapy of experimental lactational mastitis in mice].
More severe mastitis on infection with Proteus was shown on a standardized model of experimental lactation mastitis of mice caused by Staphylococcus, Proteus and their mixture. Significant differences in the morphological pictures of the staphylococcal and Proteus mastitis were noted. A pronounced effect was observed with the use of kanamycin in combination with fuzidin in treatment of experimental mastitis of various etiology.
D000818:Animals; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005672:Fusidic Acid / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D007775:Lactation Disorders / Q000188:drug therapy*; D008413:Mastitis / Q000188:drug therapy*; D051379:Mice; D010400:Penicillin G / Q000627:therapeutic use; D011247:Pregnancy; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis; D013203:Staphylococcal Infections / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use
D007612:Kanamycin; D005672:Fusidic Acid; D010400:Penicillin G; D013307:Streptomycin
Khimioterapiia éksperimental'nogo laktatsionnogo mastita u mysheĭ.